Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-12-02
2000-08-15
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 21, 424 852, 530385, A61K 3842
Patent
active
061036900
ABSTRACT:
The invention is directed to a method for the prophylaxis or treatment of an animal for deleterious physiological effects such as systemic hypotension caused by nitric oxide production induced by a biological response modifier. Examples of such biological response modifiers include but are not limited to a cytokine and an endotoxin. The invention is also directed to a method for the treatment of septic shock.
REFERENCES:
patent: 4061736 (1977-12-01), Morris et al.
patent: 4584130 (1986-04-01), Bucci et al.
patent: 4598064 (1986-07-01), Walder
patent: 4751068 (1988-06-01), Bickar et al.
patent: 5028627 (1991-07-01), Kilbourn et al.
patent: 5082642 (1992-01-01), Bickar et al.
patent: 5296466 (1994-03-01), Kilbourn et al.
patent: 5334706 (1994-08-01), Przybelski
patent: 5480866 (1996-01-01), Bonaventura et al.
patent: 5510464 (1996-04-01), Przybelski
patent: 5674836 (1997-10-01), Kilbourn et al.
Moncada et al., Pharmacol. Reviews, vol. 43(2), pp. 109-142 1991.
Moncada et al., Biochemical Pharmacol., vol. 37(13) pp. 2495-2501 1988.
Kosaka et al., Free Radical Biol. & Medicine, vol. 7, pp. 653-658 1989.
Parrat et al., Applied Cardiopulmonary & Pathophysiol. vol. 4, pp. 143-149 1991.
Cross et al., Infection and Immunity, vol. 61(7) pp. 2741-2747 Jul. 1993.
Martin et al., Jour. of Pharmacology & Experimental Therapeutics, vol. 232(3), pp. 708-716 1985.
Kilbourn et al., Proc. Natl. Acad. Sci, vol. 87, pp. 3629-3632 May 1990.
Buga et al, Europ. Journ. Pharmacol., vol. 161, pp. 61-72 1989.
Offenstadt G. et al., Pathol. Biol. (Paris), vol. 41 (8 Part 2), pp. 820-831 Oct. 1993.
Odaka A. et al, Journal Saitama Med. School, vol. 20(4), pp. 321-326 1993.
Casey et al., Annals of Int. Med., vol. 119(8), pp. 771-778 Oct. 1993.
Petros et al. ,The Lancet, vol. 338, pp. 1557-1558 1991.
Kilbourn et al., Biochem. Biophy. Res. Commun., vol. 172(3), pp. 1132-1138 1990.
Starnes et al., Journal of Immunol., vol. 145, (12) pp. 4185-4191 1990.
Aisaka et al., "N.sup.G -Methylarginine,an Inhibitor of Endothelium-DerivedNitric Oxide Synthesis, is a Potent Pressor Agent in the Guinea Pig: Does Nitric Oxide Regulate Blood Pressure in Vivo?" Biochemical and Biophysical Research Communications, 160(2):881-886, 1989.
Aranow et al., "Effect of Human Hemoglobin on Systemic and Regional Hemodynamics in a Porcine Model of Endotoxemic Shock," Crit. Care Med., 2495):807-814, 1996.
Baur, "The Evolution of Methaemalbumin," Comp. Biochem. Physiol., 30:657-664, 1969.
Bickar et al., "Carbon Monoxide-Driven Reduction of Ferric Heme and Heme Proteins," Journal of Biological Chemistry, 259(17):10777-10783,1984.
Bone, "A Critical Evaluation of New Agents for the Treatment of Sepsis," JAMA 266(12):1686-1691, 1991.
Bone et al., "Comparison of Different Doses of Pyridoxalated hemoglobin Polyethylene Conjugate in the Treatment of Hyperdynamic Sepsis," Society of Critical Care Medicine Conference, New Orleans, Feb. 5-9, 1996.
Bone et al., "Effects of Nitric Oxide Scavenging on Sheep Pancreas and Liver During Sepsis," Experimental Biology '96, Annual meeting of professional Research Scientists, Washington, D.C., Apr. 14-17, 1996.
Bone et al., "Hemodynamic Effects of Nitric Oxide Synthase Inhibition and Nitric Oxide Scavenging in Endotoxemic Sheep," International Anesthesia Research Society, 71st Clinical and Scientific Congress, San Francisco, California, Mar. 14-18, 1997.
Bone et al., "Hemodynamic Effects of Pyridoxalated Hemoglobin PolyoxyethyleneConjugate (PHP) in Conscious Sheep During Septic Shock," American Society of Anesthesiologist,Atlanta, 1995.
Bone et al., "Nitric Oxide Synthase Inhibition Versus Nitric Oxide Scavenging in Sepsis," 68th Scientific Sessions of the American Heart Association, Anaheim, California, Nov. 13-16, 1995.
Bone, "The Pathogenesis of Sepsis," Ann. Int. Med. 115:457-469, 1991.
Bonkovsky et al., "Intravenous Heme-Albumin Acute Intermittant Prophyria: Evidence for Repletion of Depatic Hemoproteins and Regulatory Heme Pools," The American Journal of Gastroenterology, 86(8):1050-1056, 1991.
Brady et al., "Nitric Oxide Production within Cardiac Myocytes Reduces their Contractility in Endotoxemia," Am. J. Physiol., 263 (Heart Circ. Physiol. 32):H1963-H1966, 1992.
Buga et al., "Endothelium-DerivedNitric Oxide Relaxes Nonvascular Smooth Muscle," European Journal of Pharmacology, 161:61-72, 1989.
Chevion et al., "Iron-NitrosylBond configuration in Nitrosyl-Hemoproteins: A Comparative EPR Study of Hemoglobin A and Hemoglobin Kansas," Israel Journal of Chemistry, 15:311-317, 1976.
Chong et al., "Determination of Methaemalbumin in Plasma," J. Clinical Pathology, 20:211-212, 1967.
Collier and Vallance, "Second Messenger Role for NO Widens to Nervous and Immune Systems," Trends in PharmacologicalSciences Including ToxicologicalSciences, Elseview Science Publishers, Ltd., front page and pp. 428-431, 1989.
Cross et al., "Choice of Bacteria in Animal Models of Sepsis," Infection and Immunity, 61(7):2741-47, 1993.
Culotta et al., "No News Is Good News", Science, 258, 1862-1865, 1992.
Finkel et al., "Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide," Science, 257:387-389, 1992.
Fischer, Bone and McGuire, "Pyridoxalated Hemoglobin PolyoxyethyleneConjugate (PHP) Increases Effectiveness of Norepinephrine in Ovine Sepsis," International Anesthesia Research Society, 71st Clinical and Scientific Congress, San Francisco, California, Mar. 14-18, 1997.
Geokas et al., "Methemalbumin in the Diagnosis of Acute Hemorrhagic Pancreatis," Annals of Internal Medicine, 81:483-486, 1974.
Glauser, M.P., et al. "Septic Shock: Pathogenesis," The Lancet, 338:732-736, 1991.
Gross et al., "Cytokine-activatedEndothelial Cells Express an Isotype of Nitric Oxide Synthase Which is Tetrahydrobiopterin-Dependent. Calmodulin-Independentand Inhibited by Arginine Analogs with a Rank-Order of Potency Characteristic of Activated Macrophages," Biochemical and Biophysical Research Communications, 178(3):823-829, 1991.
Gruetter et al., "Coronary Arterial Relaxation and Guanylate Cyclase Activation by Cigarette Smoke, N-Nitrosonornicotineand Nitric Oxide," J. Pharmcology and Experimental Therapeutics, 214(1):9-15, 1980.
Hayes et al., "Boosting oxygen Delievery Was Not Effective in Critically Ill Patients," Annals of inernal Medicine, 121(12):63, 1994.
Hayes et al., "Elevation of systemic Oxygen Delivery in the Treatment of Critically Ill Patients," N Engl. J. Med., 330(24):1717-1722, 1994.
Ignarro et al., "Endothelium-DerivedRelaxing Factor Produced and Released from Artery and Vein is Nitric Oxide," Proc. Natl. Acad. Sci. USA, 84:9265-9269, 1987.
Johnston, "Molecular Science Sets Its Sights on Septic Shock," J. NIH Res. 3:61-65, 1991.
Kilbourn et al., "Activated Macrophages Secrete a Soluble Factor that Inhibits Mitochondrial Respiration of Tumor Cells," The Journal of Immunology, 133(5):2577-2581, 1984.
Kilbourn and Belloni, "Endothelial Cell Production of Nitrogen Oxides in Response to Interferon .gamma. in Combination with Tumor Necrosis Factor, Interleukin-1, or Endotoxin," Journal of the National Cancer Institute, 82:772-776, 1990.
Kilbourn et al., "N.sup.G -Methyl-L-arginineInhibits Tumor Necrosis Factor-Induced Hypotension: Implications for the Involvement of Nitric Oxide," Proc. Natl. Acad. Sci. USA, 87:3629-3632, 1990.
Kilbourn et al., "Overproduction of Nitric Oxide in Cytokine-Mediatedand Septic Shock," J. Natl Cancer Inst., 84(11):827-831, 1992.
Kilbourn et al., "Reversal of Endotoxin-MediatedShock by N.sup.G -Methyl-L-Arginine,an Inhibitor of Nitric Oxide Synthesis," Biochemical and Biophysical Research Communications, 172(3):1132-1138, 1990.
Kosaka et al., "Detection of Nitric Oxide Production in Lipopoysaccharide-TreatedRats by ESR Using Carbon Monoxide Hemoglobin", Biochem. and Biophys. Res. Commun., 184(2):1119-1124, 1992.
Kosaka et al., "The Interaction Between Nitrogen Oxides and Hemoglobin and Endothelium-Derived Relaxing Factor," Free Radical Biology and Medicine, 7:653-658, 1989.
Koshland, Jr., "Editorial--The Molecule of the Year", Science, 258:1861, 1992.
Kruszyna et al., "Nitrite Conversion to Nitric Oxi
Bonaventura Joseph
De Angelo Joseph
Kilbourn Robert G.
Apex Bioscience, Inc.
Board of Regents , The University of Texas System
Duke University
Sayala Chhaya D.
LandOfFree
Prevention or inhibition of pathogenic syndromes caused by nitri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention or inhibition of pathogenic syndromes caused by nitri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention or inhibition of pathogenic syndromes caused by nitri will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2006880